Loading
We have very little insider data for 台新藥 so far: the most recent filing dates from 1 August 2024. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
1 of 1 declaration
台新藥 is a pharmaceutical company focused on the development of innovative drugs. It is listed on the XTAI market.